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Cognitive processes such as visual perception and selective
attention induce specific patterns of brain oscillations [1–6].
The neurochemical bases of these spectral changes in
neural activity are largely unknown, but neuromodulators
are thought to regulate processing [7–9]. The cholinergic
system is linked to attentional function in vivo [10–13],
whereas separate in vitro studies show that cholinergic
agonists induce high-frequency oscillations in slice prepa-
rations [14–16]. This has led to theoretical proposals
[17–19] that cholinergic enhancement of visual attention
might operate via gamma oscillations in visual cortex,
although low-frequency alpha/beta modulation may also
play a key role. Here we used MEG to record cortical oscilla-
tions in the context of administration of a cholinergic agonist
(physostigmine) during a spatial visual attention task in
humans. This cholinergic agonist enhanced spatial attention
effects on low-frequency alpha/beta oscillations in visual
cortex, an effect correlating with a drug-induced speeding
of performance. By contrast, the cholinergic agonist did
not alter high-frequency gamma oscillations in visual
cortex. Thus, our findings show that cholinergic neuromo-
dulation enhances attentional selection via an impact on
oscillatory synchrony in visual cortex, for low rather than
high frequencies. We discuss this dissociation between
high- and low-frequency oscillations in relation to proposals
that lower-frequency oscillations are generated by feedback
pathways within visual cortex [20, 21].
Results
Neural processing of sensory signals originating from an
attended location is thought to be enhanced by changes in
oscillatory neural activity. Low-frequency alpha and beta oscil-
lations in attended neuronal representations can be sup-
pressed even before an expected stimulus appears (and
enhanced for unattended) [5, 6]. This is thought to reflect
up- and downregulation in the excitability of relevant neuronal
populations [22]. Conversely, stimulus induced high-
frequency gammaoscillations for attended neuronal represen-
tation are enhanced [1–4] and this is thought to increase their
efficacy in driving postsynaptic neurons engendering privi-
leged access to further processing stages [1, 23]. As for*Correspondence: markus.bauer@gmail.comoscillations in general, the neurochemical pathways support-
ing these spectral changes are unknown but theoretical
proposals suggest that an enhancement in high-frequency
gamma oscillations is driven by cholinergic activity [17–19].
However, alpha oscillations are also known to be influenced
by cholinergic neuromodulation [24–27].
Here we tested the impact of a cholinergic pharmacological
intervention on brain oscillations during an attentional task in
humans. Specifically, we recorded magnetoencephalography
(MEG) while participants performed a spatial visual attention
task (Figure 1), either under treatment with physostigmine
[10, 11] as a cholinergic agonist or under placebo.
We recruited 16 participants who underwent both drug and
placebo sessions (counterbalanced order) during this task. A
central precue at trial start indicated which hemifield should
be attended for a subsequently presented bilateral pair of grat-
ings (see Figures 1B and 1C). The task was to discriminate
orientation (clockwise or anticlockwise tilt relative to diagonal,
titrated to yieldw90% accuracy) for the attended hemifield on
each trial.
Under physostigmine, performance was faster than placebo
(mean 779.8 ms versus 819.2 ms, mean speeding of 39.4 ms)
without accuracy cost (mean 90% correct under physostig-
mine, 89% for placebo, n.s.). This difference was significant
for reaction time (RT, t = 21.84, p < 0.05), when the order of
drug and placebo was taken into account, as well as for
inverse efficiency (combining RT and accuracy into a single
value [28], t = 22.52, p < 0.05), and for the latter this was
significant also without taking the order-effect into account
(t = 21.97, p < 0.05). Thus, the drug improved performance,
extending previous demonstrations that cholinergic enhance-
ment can improve attentional processing.
We performed a time-frequency (t-f) analysis on MEG
time courses projected onto the cortical surface, using a
source-reconstruction method (see Supplemental Experi-
mental Procedures) similar to previous studies [3, 4] to test
the impact of the cholinergic agonist on well-known changes
in oscillatory activity related to visuospatial attention. Direct-
ing attention to the left or right hemifield is known to suppress
contralateral and/or increase ipsilateral alpha/beta activity
[5, 6, 22], whereas gamma synchronization is enhanced [1–4]
contralateral to the attended hemifield in visual cortex.
Accordingly we tested for the expected symmetric attentional
‘‘hemispheric lateralization’’ effects in visual cortex (see
Experimental Procedures for our formal symmetry constraint),
then assessed any impact of physostigmine versus placebo
upon either alpha/beta or gamma spatial attention effects.
Cholinergic Enhancement of Alpha/Beta Spatial
Attention Effects
As expected [5, 6], alpha/beta hemispheric lateralization
effects resulting from attended hemifield emerged in the
preparatory cue period for occipital, parietal, andmotor cortex
(Figures 2A–2D), peaked around expected target onset,
and then returned back to baseline levels. The novel result
is that here alpha/beta spatial attention effects on visual
cortex were enhanced by our cholinergic manipulation,
being more pronounced under physostigmine than placebo
AB
C
Figure 1. Experimental Timeline and Stimuli
(A) Physostigmine or placebo was administered intravenously starting
25 min prior to onset of the visuospatial attention task and concurrent
MEG recording, then continuing until 15 min prior to end of experimental
session.
(B) Each trial began with onset of a symbolic cue (right or left arrow, as
shown) for 500 ms, indicating which hemifeld to attend. Participants fixated
the central cross throughout the remainder of the trial, which comprised
a 0.8–1.2 s (rectangular distribution) cue-target interval, followed by presen-
tation of bilateral gratings for 500 ms, with up to 2.2 s for participants to
make the tilt judgement (clockwise or counterclockwise relative to diagonal)
for the grating in the attended hemifield.
(C) Example display of bilateral gratings, spatial frequency 1.2 cycles/
degree, circular window of 7 degrees, centered at 8 degrees eccentricity
along the horizontal meridian.
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398(see Figures 2E and 2F for direct comparison, p < 0.0001,
uncorrected). This cholinergic enhancement of alpha/beta
spatial attention effects had a maximum in parieto-occipital
cortex (see Table S1 for coordinates) and was evident both
before and after stimulus onset. Because the parieto-occipital
sulcus itself has been tightly linked to posterior alpha oscilla-
tions [29, 30] and even cholinergic neuromodulation [26, 27],
we had a closer look at this region and placed a spatial filter
in the left and right bank of the parieto-occipital sulcus. This
revealed a clear maximum in a cholinergic enhancement
effect on spatial attention in the poststimulus phase in the
classical alpha band (peak frequency of 10 Hz, see Figure S1,
p < 0.005). Notably, despite the fact that some of these effects
were clearly in the poststimulus phase, the observed atten-
tional lateralization and its enhancement by the cholinergic
agonist was largely independent of stimulus-evoked compo-
nents (see also [4]), as indicated by the fact that subtraction
of the latter from individual trials did not change these results
(Figure S1).No Cholinergic Modulation of Gamma Attention Effects
in Visual Cortex
Consistent with previous reports [1–4], we found lateralized
effects due to attended hemifield on gamma activity for visual
cortex (p < 0.0001, uncorrected), extending into lateral occip-
ital and ventral occipito-temporal cortex; see Figure 3. These
gamma spatial attention effects emerged rapidly after stimulus
onset and then endured for w500 ms. But note that these
gamma attention effects were clearly not enhanced by physo-
stigmine here, being highly reproducible in both the drug
and placebo sessions (see Figure 3), with no significant
difference (p > 0.2, was actually for slightly reduced gamma
attentional effects under physostigmine). Likewise, stimulus-
related visual gamma responses, due merely to onset of the
visual gratings independent of attended hemifield, were also
unaffected by physostigmine (see Figure S2). We note for
completeness (and to show that gamma elsewhere could be
affected) that there was a clear enhancement of a poststim-
ulus-induced gamma-band response in frontal cortex (p <
0.01, uncorrected, see Figure S2). The impact of the drug on
oscillations in early visual cortex was thus highly specific for
the alpha/beta bands.
Brain-Behavior Relations Induced by the Cholinergic
Agonist
Finally we turned to possible relations between the neurophys-
iological effects and performance effects of our cholinergic
intervention. We correlated the participant-by-participant
drug effect on inverse efficiency scores (combining response
speed and accuracy) to each of the neurophysiological effects
described above (and as depicted in Figures 2, 3, S1, and S2)
for the t-f windows shown. Note that these t-f windows had
been selected independent of behavior, based either on atten-
tional contrast in agreementwith the literature or the difference
between drug and placebo (Figures S1 and S2). The only
significant brain-behavior relation observed was between
drug-related performance speeding and the drug-induced
poststimulus alpha spatial attention effects in the parieto-
occipital sulcus (r = 0.65, p < 0.01). Although the effect in the
extended time-frequency window in the lateral parts of pari-
eto-occipital cortex as shown in Figures 2E and 2F were not
significantly related to the behavioral effects, the poststimulus
aspect (0–200 ms) was significant here, too (r = 0.52, p < 0.05).
Given the limitation of this correlation to the poststimulus
period, we further investigated whether this effect might
by itself depend on any stimulus-evoked components but
also checked on general effects of alpha/beta power irrespec-
tive of spatial attention. To this endwesubtracted the stimulus-
evoked field from the spectrograms (as in Figure S1) and
computed a partial correlation analysis removing any general
effects of alpha/beta power. Figure S3 shows the scatterplot
for this analysis and reveals that the partial correlation for alpha
lateralization in the parieto-occipital sulcus increased to r =
0.71 (p < 0.01) but decreased for the lateral aspects of parieto-
occipital cortex (r = 0.41, p > 0.05). Thus, the key impact of
the cholinergic agonist was upon alpha/beta oscillations
modulated top-down by spatial attention in visual cortex. By
contrast, gamma oscillations in visual cortex were unaffected.
Discussion
Here we demonstrate via a causal intervention with a cholin-
ergic agonist (physostigmine) that cholinergic neuromodula-
tion augments the top-down impact of spatial attention on
Figure 2. Spatial Attention and Alpha/Beta Oscillations
(A) Time-frequency (t-f) profile for effect of spatial atten-
tion in the placebo session for symmetric hemispheric
lateralization effects of Attention Left minus Attention
Right at low frequency oscillations. Time zero corre-
sponds to target onset in this and all subsequent
t-f plots, and the color bar indicates t values. The
t-f plot combines analogous effects in the left and right
hemisphere.
(B) The topography reveals suppressed/enhanced
alpha/beta power (t-f window marked in A) in the hemi-
sphere contralateral/ipsilateral to the attended hemifield,
as expected (blue colors represent suppression, red
enhancement).
(C and D) T-f profile for corresponding effect of spatial
attention in the physostigmine condition, with topog-
raphy shown in (D); note the enhanced effect compared
with (A) and (B).
(E) T-f profile for the direct contrast of spatial attention
effect in physostigmine minus placebo conditions, with
topography shown in (F).
(F) The cholinergic enhancement is localized to parieto-
occipital cortex, an area tightly linked to alpha oscilla-
tions (see also Figure S1 for closer investigation of the
parieto-occipital sulcus). Topographies are thresholded
at p < 0.05, uncorrected, but for symmetric voxel pairs
(see Experimental Procedures).
Cholinergic Enhancement of Attentional Synchrony
399oscillations in human visual cortex, specifically for low-
frequency alpha/beta bands. Previous studies show that
cholinergic agonists enhance the hemodynamic BOLD
response [10, 11] to attended stimuli in visual cortex or
spike-rates recorded invasively [13] in primary visual cortex
but the studies had not examined oscillatory phenomena.
Although our results show the samepattern of spatial attention
effects as a previous MEG study on spatial attention [4]—
contralateral suppression (or/and ispilateral enhancement) of
alpha/beta oscillations and contralateral enhancement of
gammaoscillations—we show that a cholinergic enhancement
via physostigmine boosts attentional alpha/beta effects in
human visual cortex (Figure 2) but did not impact gamma
effects in visual cortex (Figure 3; see also Figure S2).Moreover,
the cholinergic impact on alpha/beta spatial attention effects
were correlated to a drug-induced improvement in perfor-
mance (Figure 4), such that strong attentional lateralization
coincided with more efficient task processing, whereas any
potential drug effect on visual gamma phenomena did not
show such a correlation. Our alpha/beta findings provide a
new line of evidence for the emerging view that low-frequency
oscillations in visual cortex (and sensory cortex more gener-
ally) play a key role in gating sensory processing [6, 22, 31].The specific relation to the drug-enhanced
performance speeding here indicates that the
cholinergic impact on attentional alpha/beta
effects is not merely epiphenomenal.
In contrast to the impact on alpha/beta
attention effects, the robustly observed
gamma effects resulting from attended hemi-
field in visual cortex were not modified by the
drug. This is a surprising outcome for theories
[17–19] proposing that cholinergic neuromo-
dulation impacts attentional selection by
modulating gamma synchrony in particular.
But those proposals were probably influenced
by findings from hippocampus [14–16] orauditory cortex of anesthetized animals [24, 25] after cholin-
ergic manipulations, not from recordings in visual cortex
during an attention task with a cholinergic intervention. More-
over, the one invasive study to date [32] that examined cholin-
ergic modulation of visual cortex while recording oscillations
(albeit in anesthetized cats, without any attention task) found
no immediate effect on the visually driven gamma response,
analogous to our results (Figure S2) for awake humans in
a cognitive task that allowed us to document spatial attention
effects also (Figure 3). Note that we did, however, find an
enhanced gamma-band response (after grating onset) in
right frontal cortex (Figure S2), a brain structure that is inti-
mately involved in control of attention [33] although it did not
correlate with the performance speeding here. Likewise, in
rats, frontal gamma oscillations may also depend on cholin-
ergic activation [34].
Our findings suggest that cholinergic enhancement affects
oscillatory activity in specific frequency bands, but differen-
tially for distinct brain regions. This may relate to differential
distribution of cholinergic receptors [35] and/or regional differ-
ences in circuitry, e.g., laminar activation patterns. One poten-
tial explanation for this arises from recent monkey studies
[20, 21]. These highlight that gamma synchrony in visual cortex
Figure 3. Spatial Attention and Gamma Oscilla-
tions
(A) Time-frequency profile for symmetric hemi-
spheric lateralization effects of Attention Left
minus Attention Right for high frequency oscilla-
tions under placebo.
(B and C) Topography of the high-frequency
spatial attention effects under placebo for the
time-frequency window marked in (A), shown in
posterior view (B) or shown in ventral view (C),
i.e., seen from below. Note that hot colors in the
topographies indicate enhanced power contra-
lateral to the attended hemifield, cold colors indi-
cate reduced power ipsilateral to the attended
hemifield.
(D–F) Corresponding data now shown under
physostigmine. Note the high reproducibility of
the spatial attention effects on gamma, identical
under drug/placebo. As a consequence there
was no significant enhancement of gamma atten-
tion effects by the drug (the nonsignificant trend
was actually for slightly stronger gamma atten-
tion effects under placebo). All values plotted
are t values for the contrast of Attention Left
minus Attention Right.
Topographies are thresholded at p < 0.05, uncor-
rected, but for symmetric voxel pairs (see Exper-
imental Procedures). See also Figure S2.
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400involves superficial (supragranular) feedforward layers,
whereas alpha/beta synchrony involves predominantly the
deeper (infragranular) feedback receiving layers. In the context
of the present finding of cholinergic influence on alpha/beta,
but not gamma, oscillations within human visual cortex, this
raises the intriguing possibility of cholinergic enhancement
primarily impacting feedback layers in the context of visual
attention [35, 36]. Feedback influences are presumably key
to top-down attentional influences. Although some proposals
[37, 7] have emphasized enhanced bottom-up processing
because of cholinergic modulation, other accounts propose
cholinergic enhancement of attentional influences [8–13]. Our
neurophysiological findings for human visual cortex document
an example of the latter influence, yet, interestingly, we see
this effect to extend well into the poststimulus period, sug-
gesting a cholinergic impact on the interaction of bottom-up
and top-down influences.
The drug used here, physostigmine, influences both nico-
tinic and muscarinic receptors [8], and it may be of interest
to further distinguish the specific contributions of these in
future work. Nevertheless, physostigmine has proven useful
for studying the impact of the cholinergic system on neural
processing in many previous studies [8–11] and is of particular
interest as a drug applicable to humans. The importance of our
results is that they provide the first evidence on how the cholin-
ergic system modulates cortical oscillations, in the context of
a visuospatial attention task, illustrating the power and poten-
tial of combining neuropharmacology with MEG [38, 39] and
documenting the importance of low-frequency (alpha/beta)
oscillations for visual attention.
Experimental Procedures
Participants
Sixteen healthy male volunteers (mean age 25.6 years, SD 5.7 years) partic-
ipated after informed consent in accord with ethical clearance. Participants
trained on the task and then performed two MEG sessions: one under drug,
one with placebo in a double-blind crossover design.Task
Two visual gratings appeared, one in each hemifield centered at 8 degrees
eccentricity (see Figure 1). Each trial started with a precue (central arrow
pointing left or right for 500 ms) followed by a cue-target interval (length
varied uniformly and unpredictably from 800 to 1200ms), then onset of bilat-
eral gratings for 500 ms. The task was to judge a tilt-offset for the grating in
the cued hemifield (clockwise or counterclockwise relative to the diagonal),
as indicated by pressing a right or left button with the corresponding index
finger as quickly and accurately as possible. The actual tilt offset was
titrated to yield w90% correct performance; see Supplemental Experi-
mental Procedures for further details.
Procedure
For the pharmacological MEG sessions, the responsible physician adminis-
tered either the drug (0.01 mg physostigmine per kg bodyweight and
infusion time and 0.2 mg glycopyrrolate as a peripheral antagonist; see
Supplemental Information and [10, 11]) or the equivalent amounts of a saline
solution for placebo via an intravenous line.
Behavioral Data Analysis
We performed a regression analysis on the difference between drug and
placebo in RT with drug/placebo session order as a covariate. The same
analysis was performed for inverse-efficiency behavioral scores [36], which
combine RT and accuracy as RT divided by proportion correct.
MEG Recording and Analysis
MEG data were recorded continuously with a CTF Omega system at
sampling rate of 600 Hz and analysis was primarily implemented with Field-
Trip [40], unless stated. Procedures for recording, preprocessing, and arti-
fact treatment followed previous work closely [1] as further described in
Supplemental Experimental Procedures. For source reconstruction, we
used a single-shell forward model [41] that was derived from the cortical
sheets of each participant by a nonlinear warp of their brain to theMNI brain
via SPM8 [42]. We used a beamforming approach [43, 44] to project the
sensor data onto a (spatially) downsampled cortical grid representation.
We then performed a time frequency analysis of the time courses on sour-
ce level. For low-frequency bands (2.5–40 Hz), a wavelet analysis was
computed and for the high-frequency bands, a multitaper analysis was
computed.
Analysis for Spatial Attention Effects
In order tominimize false positives, by design we implemented the following
formal procedure to test here for symmetrically lateralized spatial attention
Figure 4. Brain-Behavior Relations
Scatterplots with regression lines showing significant correlation of drug
impact on poststimulus alpha/beta spatial attention effects with inverse effi-
ciency scores for parieto-occipital cortex (see Figures 2E, 2F, and S1).
(A) Correlation with the lateral parts of parieto-occipital cortex (Figure 2F,
10–20 Hz, 0–200 ms).
(B) Correlationwith anROI in the parieto-occipital sulcus (Figure S1), a struc-
ture tightly linked with alpha oscillations at the t-f window where the drug
effect is maximal there (5–15 Hz, 0–350 ms).
Difference of attentional lateralization (Attention Left minus Attention Right)
in power for right minus left hemispheres are shown on the y axis, differ-
ences of inverse efficiency is shown on the x axis. Each point gives differ-
ence scores for one participant, in blue the subjects where the drug session
followed placebo and in green where drug preceded placebo. Negative
values on the x and y axis indicate stronger effects in the expected direction
(stronger hemispheric lateralization and faster processing for the physostig-
mine condition). Subjects for whom the drug was administered in the
second session tend to have stronger effects. See also Figure S3.
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401effects. To test for themain effect of spatial attention, t tests were calculated
for the difference between ‘‘Attend_Left’’ and ‘‘Attend_Right’’ for each grid
point in the respective time-frequency windows. The symmetry constraint
was operationalized by retaining only grid points that showed a significant
difference (p < 0.05) in the above contrast (Attend_Left versus Attend_Right)
and had a corresponding grid point for the reverse contrast (see Supple-
mental Experimental Procedures for further details). Subsequent tests for
any drug modulation of attention effects also had the mirror symmetry
constraint on paired t tests of attentional hemispheric lateralization.
Correlation of Physiological Measures with Behavior
We related the drug impact on inverse efficiency to the drug impact on those
MEG results of interest already reported to avoid a blind search through the
entire brain-time-frequency matrix.Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and one table and can be found with this article online
at doi:10.1016/j.cub.2012.01.022.
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